MOH — authorised 24 April 2024
- Marketing authorisation holder: ALEMBIC THERAP
- Status: likely_approved
MOH authorised Pivamdinocillin on 24 April 2024
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 24 April 2024.
ALEMBIC THERAP holds the UAE marketing authorisation.